Identification of a new ribonucleoside inhibitor of ebola virus replication

Viruses

Volumn 7, Issue 12, 2015, Pages 6233-6240

  Reynard, Olivier ^a   Nguyen, Xuan Nhi ^a   Alazard Dany, Nathalie ^a   Barateau, Véronique ^a   Cimarelli, Andrea ^a   Volchkov, Viktor E ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Antiviral; Ebola; Filovirus; Inhibitors; Marburg; Polymerase

Indexed keywords

2,3 DIDEOXCYTIDINE; ABACAVIR; BETA DEXTRO N4 HYDROXYCYTIDINE; CYTIDINE DERIVATIVE; DIDANOSINE; EMTRICITABINE; ENHANCED GREEN FLUORESCENT PROTEIN; HYDROXYUREA; INOSINATE DEHYDROGENASE; LAMIVUDINE; PLASMID DNA; STAVUDINE; TENOFOVIR; UNCLASSIFIED DRUG; ZIDOVUDINE; ANTIVIRUS AGENT; CYTIDINE; N(4)-HYDROXYCYTIDINE;

AFRICA; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG SCREENING; EBOLAVIRUS; EC50; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; MARBURGVIRUS; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; VIRUS REPLICATION; VIRUS TRANSMISSION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; PHYSIOLOGY; VERO CELL LINE;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CYTIDINE; EBOLAVIRUS; VERO CELLS; VIRUS REPLICATION;

EID: 84949493152     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7122934     Document Type: Article

References (23)

1. Incident Management System Ebola Epidemiology Team, CDC; Guinea Interministerial Committee for Response Against the Ebola Virus; World Health Organization; CDC Guinea Response Team; Liberia Ministry of Health and Social Wealfare; CDC Liberia Response Team; Sierra Leone Ministry of Health and Sanitation; CDC Sierria Leone Response Team; Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC; Centers for Disease Control and Prevention (CDC). Update: Ebola virus disease epidemic-West Africa, February 2015. MMWR Morb. Mortal. Wkly. Rep. 2015, 64, 186-187.
2. Kuhn, J.H.; Becker, S.; Ebihara, H.; Geisbert, T.W.; Johnson, K.M.; Kawaoka, Y.; Lipkin, W.I.; Negredo, A.I.; Netesov, S.V.; Nichol, S.T.; et al. Proposal for a revised taxonomy of the family filoviridae: Classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 2010, 155, 2083-2103. [CrossRef] [PubMed]
3. Feldmann, H.; Klenk, H.D.; Sanchez, A. Molecular biology and evolution of filoviruses. Arch. Virol. Suppl. 1993, 7, 81-100. [PubMed]
4. Volchkov, V.E.; Volchkova, V.A.; Slenczka, W.; Klenk, H.D.; Feldmann, H. Release of viral glycoproteins during Ebola virus infection. Virology 1998, 245, 110-119. [CrossRef] [PubMed]
5. Volchkova, V.A.; Feldmann, H.; Klenk, H.D.; Volchkov, V.E. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology 1998, 250, 408-414. [CrossRef] [PubMed]
6. Volchkova, V.A.; Dolnik, O.; Martinez, M.J.; Reynard, O.; Volchkov, V.E. RNA editing of the GP gene of Ebola virus is an important pathogenicity factor. J. Infect. Dis. 2015, 212, S226-S233. [CrossRef] [PubMed]
7. Feldmann, H.; Geisbert, T.W. Ebola haemorrhagic fever. Lancet 2011, 377, 849-862. [CrossRef]
8. Mohammadi, D. Ebola vaccine trials back on track. Lancet 2015, 385, 214-215. [CrossRef]
9. Browne, M.J.; Mayer, K.H.; Chafee, S.B.; Dudley, M.N.; Posner, M.R.; Steinberg, S.M.; Graham, K.K.; Geletko, S.M.; Zinner, S.H.; Denman, S.L.; et al. 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: A phase I trial. J. Infect. Dis. 1993, 167, 21-29. [CrossRef] [PubMed]
10. Schooley, R.T.; Ruane, P.; Myers, R.A.; Beall, G.; Lampiris, H.; Berger, D.; Chen, S.S.; Miller, M.D.; Isaacson, E.; Cheng, A.K.; et al. Tenofovir DF in antiretroviral-experienced patients: Results from a 48-week, randomized, double-blind study. Aids 2002, 16, 1257-1263. [CrossRef] [PubMed]
11. Fischl, M.A.; Richman, D.D.; Grieco, M.H.; Gottlieb, M.S.; Volberding, P.A.; Laskin, O.L.; Leedom, J.M.; Groopman, J.E.; Mildvan, D.; Schooley, R.T.; et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N. Engl. J. Med. 1987, 317, 185-191. [CrossRef] [PubMed]
12. Ford, N.; Shubber, Z.; Hill, A.; Vitoria, M.; Doherty, M.; Mills, E.J.; Gray, A. Comparative efficacy of lamivudine and emtricitabine: A systematic review and meta-analysis of randomized trials. PLoS ONE 2013, 8, e79981. [CrossRef] [PubMed]
13. Stuyver, L.J.; Whitaker, T.; McBrayer, T.R.; Hernandez-Santiago, B.I.; Lostia, S.; Tharnish, P.M.; Ramesh, M.; Chu, C.K.; Jordan, R.; Shi, J.; et al. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture. Antimicrob. Agents Chemother. 2003, 47, 244-254. [CrossRef] [PubMed]
14. Martinez, M.J.; Biedenkopf, N.; Volchkova, V.; Hartlieb, B.; Alazard-Dany, N.; Reynard, O.; Becker, S.; Volchkov, V. Role of Ebola virus VP30 in transcription reinitiation. J. Virol. 2008, 82, 12569-12573. [CrossRef] [PubMed]
15. Albarino, C.G.; Wiggleton Guerrero, L.; Lo, M.K.; Nichol, S.T.; Towner, J.S. Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein. Virology 2015, 484, 259-264. [CrossRef] [PubMed]
16. Bray, M.; Geisbert, T.W. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int. J. Biochem. Cell Biol. 2005, 37, 1560-1566. [CrossRef] [PubMed]
17. Jarrosson-Wuilleme, L.; Goujon, C.; Bernaud, J.; Rigal, D.; Darlix, J.L.; Cimarelli, A. Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. J. Virol. 2006, 80, 1152-1159. [CrossRef] [PubMed]
18. Hernandez-Santiago, B.I.; Beltran, T.; Stuyver, L.; Chu, C.K.; Schinazi, R.F. Metabolism of the anti-hepatitis C virus nucleoside β-D-N4-hydroxycytidine in different liver cells. Antimicrob. Agents Chemother. 2004, 48, 4636-4642. [CrossRef] [PubMed]
19. Markland, W.; McQuaid, T.J.; Jain, J.; Kwong, A.D. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: A comparison with ribavirin and demonstration of antiviral additivity with α interferon. Antimicrob. Agents Chemother. 2000, 44, 859-866. [CrossRef] [PubMed]
20. Felczak, K.; Miazga, A.; Poznanski, J.; Bretner, M.; Kulikowski, T.; Dzik, J.M.; Golos, B.; Zielinski, Z.; Ciesla, J.; Rode,W. 5-substituted N(4)-hydroxy-2'-deoxycytidines and their 5'-monophosphates: Synthesis, conformation, interaction with tumor thymidylate synthase, and in vitro antitumor activity. J. Med. Chem. 2000, 43, 4647-4656. [CrossRef] [PubMed]
21. Crary, S.M.; Towner, J.S.; Honig, J.E.; Shoemaker, T.R.; Nichol, S.T. Analysis of the role of predicted RNA secondary structures in Ebola virus replication. Virology 2003, 306, 210-218. [CrossRef]
22. Muhlberger, E.; Trommer, S.; Funke, C.; Volchkov, V.; Klenk, H.D.; Becker, S. Termini of all mRNA species of Marburg virus: Sequence and secondary structure. Virology 1996, 223, 376-380. [CrossRef] [PubMed]
23. Volchkov, V.E.; Volchkova, V.A.; Chepurnov, A.A.; Blinov, V.M.; Dolnik, O.; Netesov, S.V.; Feldmann, H. Characterization of the l gene and 5' trailer region of Ebola virus. J. Gen. Virol. 1999, 80, 355-362. [CrossRef] [PubMed]